Skip to main content
VKTX logo

VKTX

Viking Therapeutics, Inc.

$24.77

4.14%

Trade Ideas Performance

Latest Closed Trade Idea

$24.77

4.14%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

1

Social

4

About

Events of Viking Therapeutics, Inc. (VKTX)

Over the past six months, Viking Therapeutics' stock price has experienced fluctuations, with the share price on October 28, 2026, at $25.36, representing a decline of 33.56% from October 30, 2025. The stock's 52-week range has been between $23.82 and $43.15. Key events impacting the stock include the company's announcement and closing of upsized offerings of common stock and convertible senior notes in September 2026, which brought in $547.8 million net. In October 2026, Viking Therapeutics initiated its VK2735 oral Phase 3 clinical program in patients with obesity and also announced the initiation of a VK2735 oral maintenance dosing clinical trial. On October 28, 2026, the company reported its Third Quarter 2026 Financial Results. By November 2026, the stock was trading approximately 23% below its $35 secondary offering price, which some analysts viewed as a potential opportunity for investors. The stock has shown a year-to-date loss of roughly 31% as of October 26, 2026, underperforming the industry, medical sector, and S&P 500 Index.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)